Remote Monitoring of Bioelectrical Impedance in Patients With Breast Cancer–Related Lymphedema: 1-Year Pilot Longitudinal Study

Remote Monitoring of Bioelectrical Impedance in Patients With Breast Cancer–Related Lymphedema: 1-Year Pilot Longitudinal Study

Breast cancer–related lymphedema (BCRL) is a chronic complication that impairs quality of life through persistent fluid accumulation. While clinical guidelines recommend longitudinal surveillance, implementation is often limited by the logistical challenges of frequent in-clinic visits. Bioelectrical impedance analysis (BIA), specifically the segmental extracellular water–to–total body water (ECW/TBW) ratio, offers a noninvasive method for tracking fluid status.

Medigy Insights

Home-based bioelectrical impedance measurements showed potential for supporting early detection and ongoing surveillance of lymphedema, helping clinicians monitor disease progression while reducing the need for frequent in-person visits.



Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2026 Netspective Foundation, Inc. All Rights Reserved.

Built on Jun 12, 2026 at 3:36pm